Business & Finance
Inex receives positive court outcome for spin-out of Tekmira
Published in Law and Health Weekly, December 30th, 2006
In its ruling, the court approved the INEX plan of arrangement to transfer all of the company's transferable assets and liabilities to Tekmira. This includes the 2001 agreements that created Protiva Biotherapeutics, Inc., and the ongoing litigation with Protiva.
The court rejected all motions raised by Protiva to block the spin-out of Tekmira.
On September 20, 2006 shareholders of INEX voted 99.3% in favor of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Alcohol Use
Alcohol monitor achieves milestones in fight against alcohol abuse - Anesthesiology
Researchers from University of Washington, Department of Anesthesiology publish new studies and findings in the area of anesthesiology - Business & Finance
Millenium completes corporate reorganization, closes $1.475 million investment in subsidiary - Business Update
MedCom subsidiary Card Activation Technologies sends additional license agreement requests - Business Update
NDSI Healthcare, Sandata to integrate home health software and telephony technology - Business Update
Tenet reaches partial settlement with IRS, expects to make $80 million payment in Q4 2006 - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
